Proudler A - Search Results

1

Association of insulin and insulin propeptides with an atherogenic lipoprotein phenotype.

Båvenholm P, Karpe F, Proudler A, Tornvall P, Crook D, Hamsten A. Båvenholm P, et al. Among authors: proudler a. Metabolism. 1995 Nov;44(11):1481-8. doi: 10.1016/0026-0495(95)90150-7. Metabolism. 1995. PMID: 7476338

2

Insulin, intact and split proinsulin, and coronary artery disease in young men.

Båvenholm P, Proudler A, Tornvall P, Godsland I, Landou C, de Faire U, Hamsten A. Båvenholm P, et al. Among authors: proudler a. Circulation. 1995 Sep 15;92(6):1422-9. doi: 10.1161/01.cir.92.6.1422. Circulation. 1995. PMID: 7664422

3

High-density lipoprotein: relations to metabolic parameters and severity of coronary artery disease.

Tornvall P, Karpe F, Proudler A, Båvenholm P, Landou C, Olivecrona T, Hamsten A. Tornvall P, et al. Among authors: proudler a. Metabolism. 1996 Nov;45(11):1375-82. doi: 10.1016/s0026-0495(96)90118-3. Metabolism. 1996. PMID: 8931642

4

Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease.

Jovinge S, Hamsten A, Tornvall P, Proudler A, Båvenholm P, Ericsson CG, Godsland I, de Faire U, Nilsson J. Jovinge S, et al. Among authors: proudler a. Metabolism. 1998 Jan;47(1):113-8. doi: 10.1016/s0026-0495(98)90203-7. Metabolism. 1998. PMID: 9440488 Clinical Trial.

5

Relationships of insulin and intact and split proinsulin to haemostatic function in young men with and without coronary artery disease.

Båvenholm P, Proudler A, Silveira A, Crook D, Blombäck M, de Faire U, Hamsten A. Båvenholm P, et al. Among authors: proudler a. Thromb Haemost. 1995 Apr;73(4):568-75. Thromb Haemost. 1995. PMID: 7495060

6

Serum angiotensin-I-converting enzyme activity in women with cardiological syndrome X: relation to blood pressure and lipid and carbohydrate metabolic risk markers for coronary heart disease.

Proudler AJ, Crook D, Godsland IF, Collins P, Rosano GM, Stevenson JC. Proudler AJ, et al. J Clin Endocrinol Metab. 1995 Feb;80(2):696-9. doi: 10.1210/jcem.80.2.7852538. J Clin Endocrinol Metab. 1995. PMID: 7852538

7

Effect of postmenopausal oestradiol and dydrogesterone therapy on lipoproteins and insulin sensitivity, secretion and elimination in hysterectomised women.

Manassiev NA, Godsland IF, Crook D, Proudler AJ, Whitehead MI, Stevenson JC. Manassiev NA, et al. Among authors: proudler aj. Maturitas. 2002 Jul 25;42(3):233-42. doi: 10.1016/s0378-5122(02)00069-5. Maturitas. 2002. PMID: 12161048

8

Hemostatic risk factors and insulin sensitivity, regional body fat distribution, and the metabolic syndrome.

Godsland IF, Crook D, Proudler AJ, Stevenson JC. Godsland IF, et al. Among authors: proudler aj. J Clin Endocrinol Metab. 2005 Jan;90(1):190-7. doi: 10.1210/jc.2004-1292. Epub 2004 Oct 19. J Clin Endocrinol Metab. 2005. PMID: 15494459

9

Effects of a low-estrogen, desogestrel-containing oral contraceptive on lipid and carbohydrate metabolism.

Godsland IF, Crook D, Worthington M, Proudler AJ, Felton C, Sidhu M, Stevenson JC. Godsland IF, et al. Among authors: proudler aj. Contraception. 1993 Sep;48(3):217-27. doi: 10.1016/0010-7824(93)80142-i. Contraception. 1993. PMID: 8222652

10

Effects of low and high dose oestradiol and dydrogesterone therapy on insulin and lipoprotein metabolism in healthy postmenopausal women.

Godsland IF, Manassiev NA, Felton CV, Proudler AJ, Crook D, Whitehead MI, Stevenson JC. Godsland IF, et al. Among authors: proudler aj. Clin Endocrinol (Oxf). 2004 May;60(5):541-9. doi: 10.1111/j.1365-2265.2004.02017.x. Clin Endocrinol (Oxf). 2004. PMID: 15104556 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters